Lorie Gawreluk News
-
A Johnson & Johnson unit defeated at trial an Illinois woman’s claim she was harmed by a defectively designed metal-on-metal hip implant.
-
Johnson & Johnson’s DePuy unit defectively designed a metal-on-metal hip implant and was negligent, a California jury decided in the first of 10,750 lawsuits over the device to go to trial.
-
One year after Johnson & Johnson pulled 93,000 metal hip implants from the market, the company internally estimated that 37 percent of the devices would fail within 4.6 years, according to newly unsealed court records.
-
Johnson & Johnson, which is fighting more than 10,000 lawsuits over its recalled hip implants, is negotiating a potential settlement with patients that may eventually total more than $2 billion, according to five people familiar with the matter.
-
California and New York, along with Florida, agreed to join more than 40 other states in a nationwide settlement 16 months in the making that seeks to end abusive bank foreclosure practices that followed the collapse of the housing bubble, a person familiar with the matter said.
-
A former dancer withdrew her suit against Johnson & Johnson over defective hip implants on the eve of the first trial of more than 10,000 lawsuits claiming the devices left patients immobilized.
-
Johnson & Johnson won European Union approval for its $21.3 billion purchase of Synthes Inc. after agreeing to sell its DePuy Orthopaedics Trauma business to allay antitrust concerns.
-
Johnson & Johnson, which is defending against more than 10,000 lawsuits over recalled hip implants, faces its first trial of claims that the devices left some patients immobilized and in pain.
-
A metal-on-metal hip implant made by Johnson & Johnson failed in more than a quarter of cases by the sixth year after the devices were installed, according to a U.K. medical registry.
-
All pretrial proceedings in federal lawsuits against Johnson & Johnson over recalled devices used in hip-replacement surgery will be overseen by a federal judge in Ohio, a judicial panel decided.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page